Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Front Endocrinol (Lausanne) ; 14: 1217021, 2023.
Article in English | MEDLINE | ID: mdl-37554763

ABSTRACT

Introduction: Oxyntomodulin (Oxm) hormone peptide has a number of beneficial effects on nutrition and metabolism including increased energy expenditure and reduced body weight gain. Despite its many advantages as a potential therapeutic agent, Oxm is subjected to rapid renal clearance and protease degradation limiting its clinical application. Previously, we have shown that subcutaneous administration of a fibrillar Oxm formulation can significantly prolong its bioactivity in vivo from a few hours to a few days. Methods: We used a protease resistant analogue of Oxm, Aib2-Oxm, to form nanfibrils depot and improve serum stability of released peptide. The nanofibrils and monomeric peptide in solution were characterized by spectroscopic, microscopic techniques, potency assay, QCM-D and in vivo studies. Results: We show that in comparison to Oxm, Aib2-Oxm fibrils display a slower elongation rate requiring higher ionic strength solutions, and a higher propensity to dissociate. Upon subcutaneous administration of fibrillar Aib2-Oxm in rodents, a 5-fold increase in bioactivity relative to fibrillar Oxm and a significantly longer bioactivity than free Aib2-Oxm were characterized. Importantly, a decrease in food intake was observed up to 72-hour post-administration, which was not seen for free Aib2-Oxm. Conclusion: Our findings provides compelling evidence for the development of long-lasting peptide fibrillar formulations that yield extended plasma exposure and enhanced in vivo pharmacological response.


Subject(s)
Glucagon-Like Peptide 1 , Glucagon , Eating/physiology , Glucagon/metabolism , Glucagon-Like Peptide 1/pharmacology , Oxyntomodulin/chemistry , Oxyntomodulin/pharmacology , Peptide Hydrolases , Peptides/pharmacology , Receptors, Glucagon/metabolism , Animals
3.
Int J Pharm ; 604: 120719, 2021 Jul 15.
Article in English | MEDLINE | ID: mdl-34015379

ABSTRACT

The human peptide hormone Oxyntomodulin (Oxm) is known to induce satiety, increase energy expenditure, and control blood glucose in humans, making it a promising candidate for treatment of obesity and/or type 2 diabetes mellitus. However, a pharmaceutical exploitation has thus far been impeded by fast in vivo clearance and the molecule's sensitivity to half-life extending structural modifications. We recently showed that Oxm self-assembles into amyloid-like nanofibrils that continuously release active, soluble Oxm in a peptide-deprived environment. S.c. injected Oxm nanofibrils extended plasma exposure from a few hours to five days in rodents, compared to s.c. applied soluble Oxm. Here we show that Oxm fibril elongation kinetics and thermodynamics display a uniquely low temperature optimum compared to previously reported amyloid-like peptide and protein assemblies. Elongation rate is optimal at room temperature, with association rates 2-3 times higher at 25 °C than at ≥37 °C or ≤20 °C. We deduce from a combination of Cryo electron microscopy and spectroscopic methods that Oxm fibrils have a double-layered, triangular cross-section composed of arch-shaped monomers. We suggest a thermodynamic model that links the necessary molecular rearrangements during fibrillation and peptide release to the unique temperature effects in Oxm self-assembly and disassembly.


Subject(s)
Diabetes Mellitus, Type 2 , Pharmaceutical Preparations , Glucagon , Glucagon-Like Peptide-1 Receptor , Glucagon-Like Peptides , Humans , Receptors, Glucagon
4.
J Control Release ; 314: 116-124, 2019 11 28.
Article in English | MEDLINE | ID: mdl-31647980

ABSTRACT

Mycobacterium tuberculosis (Mtb) remains a major challenge to global health, made worse by the spread of multi-drug resistance. Currently, the efficacy and safety of treatment is limited by difficulties in achieving and sustaining adequate tissue antibiotic concentrations while limiting systemic drug exposure to tolerable levels. Here we show that nanoparticles generated from a polymer-antibiotic conjugate ('nanobiotics') deliver sustained release of active drug upon hydrolysis in acidic environments, found within Mtb-infected macrophages and granulomas, and can, by encapsulation of a second antibiotic, provide a mechanism of synchronous drug delivery. Nanobiotics are avidly taken up by infected macrophages, enhance killing of intracellular Mtb, and are efficiently delivered to granulomas and extracellular mycobacterial cords in vivo in an infected zebrafish model. We demonstrate that isoniazid (INH)-derived nanobiotics, alone or with additional encapsulation of clofazimine (CFZ), enhance killing of mycobacteria in vitro and in infected zebrafish, supporting the use of nanobiotics for Mtb therapy and indicating that nanoparticles generated from polymer-small molecule conjugates might provide a more general solution to delivering co-ordinated combination chemotherapy.


Subject(s)
Antitubercular Agents/administration & dosage , Isoniazid/administration & dosage , Mycobacterium tuberculosis/drug effects , Nanoparticles , Animals , Antitubercular Agents/pharmacology , Clofazimine/administration & dosage , Clofazimine/pharmacology , Delayed-Action Preparations , Disease Models, Animal , Drug Combinations , Drug Delivery Systems , Humans , Isoniazid/pharmacology , Macrophages/microbiology , Polymers/chemistry , Tuberculosis/drug therapy , Tuberculosis/microbiology , Zebrafish
5.
Nat Commun ; 8(1): 1026, 2017 10 18.
Article in English | MEDLINE | ID: mdl-29044101

ABSTRACT

The use of peptides as therapeutic agents is undergoing a renaissance with the expectation of new drugs with enhanced levels of efficacy and safety. Their clinical potential will be only fully realised once their physicochemical and pharmacokinetic properties have been precisely controlled. Here we demonstrate a reversible peptide self-assembly strategy to control and prolong the bioactivity of a native peptide hormone in vivo. We show that oxyntomodulin, a peptide with potential to treat obesity and diabetes, self-assembles into a stable nanofibril formulation which subsequently dissociates to release active peptide and produces a pharmacological effect in vivo. The subcutaneous administration of the nanofibrils in rats results in greatly prolonged exposure, with a constant oxyntomodulin bioactivity detectable in serum for at least 5 days as compared to free oxyntomodulin which is undetectable after only 4 h. Such an approach is simple, cost-efficient and generic in addressing the limitations of peptide therapeutics.


Subject(s)
Obesity/drug therapy , Oxyntomodulin/pharmacokinetics , Peptide Hormones/pharmacokinetics , Animals , Glucose/metabolism , Injections, Subcutaneous , Male , Mice , Mice, Inbred C57BL , Obesity/metabolism , Oxyntomodulin/administration & dosage , Oxyntomodulin/blood , Oxyntomodulin/chemistry , Peptide Hormones/administration & dosage , Peptide Hormones/blood , Peptide Hormones/chemistry , Rats , Rats, Sprague-Dawley
6.
Langmuir ; 32(48): 12923-12933, 2016 12 06.
Article in English | MEDLINE | ID: mdl-27934520

ABSTRACT

Nucleoside diphosphate kinases (NDPKs) are crucial elements in a wide array of cellular physiological or pathophysiological processes such as apoptosis, proliferation, or metastasis formation. Among the NDPK isoenzymes, NDPK-B, a cytoplasmic protein, was reported to be associated with several biological membranes such as plasma or endoplasmic reticulum membranes. Using several membrane models (liposomes, lipid monolayers, and supported lipid bilayers) associated with biophysical approaches, we show that lipid membrane binding occurs in a two-step process: first, initiation by a strong electrostatic adsorption process and followed by shallow penetration of the protein within the membrane. The NDPK-B binding leads to a decrease in membrane fluidity and formation of protein patches. The ability of NDPK-B to form microdomains at the membrane level may be related to protein-protein interactions triggered by its association with anionic phospholipids. Such accumulation of NDPK-B would amplify its effects in functional platform formation and protein recruitment at the membrane.


Subject(s)
Cell Membrane/chemistry , Lipid Bilayers/chemistry , Membrane Fluidity , Humans , Nucleoside-Diphosphate Kinase/chemistry , Protein Binding
7.
Proc Natl Acad Sci U S A ; 113(26): 7065-70, 2016 06 28.
Article in English | MEDLINE | ID: mdl-27298346

ABSTRACT

Intracellular α-synuclein deposits, known as Lewy bodies, have been linked to a range of neurodegenerative disorders, including Parkinson's disease. α-Synuclein binds to synthetic and biological lipids, and this interaction has been shown to play a crucial role for both α-synuclein's native function, including synaptic plasticity, and the initiation of its aggregation. Here, we describe the interplay between the lipid properties and the lipid binding and aggregation propensity of α-synuclein. In particular, we have observed that the binding of α-synuclein to model membranes is much stronger when the latter is in the fluid rather than the gel phase, and that this binding induces a segregation of the lipids into protein-poor and protein-rich populations. In addition, α-synuclein was found to aggregate at detectable rates only when interacting with membranes composed of the most soluble lipids investigated here. Overall, our results show that the chemical properties of lipids determine whether or not the lipids can trigger the aggregation of α-synuclein, thus affecting the balance between functional and aberrant behavior of the protein.


Subject(s)
Cell Membrane/metabolism , Lipid Bilayers/chemistry , Parkinson Disease/metabolism , alpha-Synuclein/chemistry , Cell Membrane/chemistry , Humans , Kinetics , Lipid Bilayers/metabolism , Protein Aggregation, Pathological/metabolism , alpha-Synuclein/metabolism
8.
J Biol Chem ; 291(13): 6664-78, 2016 Mar 25.
Article in English | MEDLINE | ID: mdl-26742848

ABSTRACT

Perilipins (PLINs) play a key role in energy storage by orchestrating the activity of lipases on the surface of lipid droplets. Failure of this activity results in severe metabolic disease in humans. Unlike all other lipid droplet-associated proteins, PLINs localize almost exclusively to the phospholipid monolayer surrounding the droplet. To understand how they sense and associate with the unique topology of the droplet surface, we studied the localization of human PLINs inSaccharomyces cerevisiae,demonstrating that the targeting mechanism is highly conserved and that 11-mer repeat regions are sufficient for droplet targeting. Mutations designed to disrupt folding of this region into amphipathic helices (AHs) significantly decreased lipid droplet targetingin vivoandin vitro Finally, we demonstrated a substantial increase in the helicity of this region in the presence of detergent micelles, which was prevented by an AH-disrupting missense mutation. We conclude that highly conserved 11-mer repeat regions of PLINs target lipid droplets by folding into AHs on the droplet surface, thus enabling PLINs to regulate the interface between the hydrophobic lipid core and its surrounding hydrophilic environment.


Subject(s)
Carrier Proteins/chemistry , Lipid Droplets/chemistry , Membrane Proteins/chemistry , Phosphoproteins/chemistry , Saccharomyces cerevisiae/metabolism , Vesicular Transport Proteins/chemistry , Amino Acid Sequence , Animals , Binding Sites , Biological Transport , COS Cells , Carrier Proteins/genetics , Carrier Proteins/metabolism , Chlorocebus aethiops , Gene Expression , Humans , Hydrophobic and Hydrophilic Interactions , Lipid Droplets/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Micelles , Models, Molecular , Molecular Sequence Data , Mutation , Perilipin-1 , Perilipin-2 , Perilipin-3 , Phosphoproteins/genetics , Phosphoproteins/metabolism , Protein Binding , Protein Interaction Domains and Motifs , Protein Structure, Secondary , Protein Transport , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/ultrastructure , Sequence Alignment , Transgenes , Vesicular Transport Proteins/genetics , Vesicular Transport Proteins/metabolism
9.
Colloids Surf B Biointerfaces ; 126: 169-77, 2015 Feb 01.
Article in English | MEDLINE | ID: mdl-25555155

ABSTRACT

Among the range of materials used in bioengineering, parylene-C has been used in combination with silicon oxide and in presence of the serum proteins, in cell patterning. However, the structural properties of adsorbed serum proteins on these substrates still remain elusive. In this study, we use an optical biosensing technique to decipher the properties of fibronectin (Fn) and serum albumin adsorbed on parylene-C and silicon oxide substrates. Our results show the formation of layers with distinct structural and adhesive properties. Thin, dense layers are formed on parylene-C, whereas thicker, more diffuse layers are formed on silicon oxide. These results suggest that Fn acquires a compact structure on parylene-C and a more extended structure on silicon oxide. Nonetheless, parylene-C and silicon oxide substrates coated with Fn host cell populations that exhibit focal adhesion complexes and good cell attachment. Albumin adopts a deformed structure on parylene-C and a globular structure on silicon oxide, and does not support significant cell attachment on either surface. Interestingly, the co-incubation of Fn and albumin at the ratio found in serum, results in the preferential adsorption of albumin on parylene-C and Fn on silicon oxide. This finding is supported by the exclusive formation of focal adhesion complexes in differentiated mouse embryonic stem cells (CGR8), cultured on Fn/albumin coated silicon oxide, but not on parylene-C. The detailed information provided in this study on the distinct properties of layers of serum proteins on substrates such as parylene-C and silicon oxide is highly significant in developing methods for cell patterning.


Subject(s)
Fibronectins/chemistry , Polymers/chemistry , Serum Albumin, Bovine/chemistry , Silicon Dioxide/chemistry , Xylenes/chemistry , Animals , Cattle , Cell Adhesion , Cells, Cultured , Mice
10.
Biomaterials ; 35(24): 6157-63, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24780165

ABSTRACT

Although protein adsorption to surface is a common phenomenon, investigation of the process is challenging due to the complexity of the interplay between external factors, protein and surface properties. Therefore experimental approaches have to measure the properties of adsorbed protein layers with high accuracy in order to achieve a comprehensive description of the process. To this end, we used a combination of two biosensing techniques, dual polarization interferometry and quartz crystal microbalance with dissipation. From this, we are able to extract surface coverage values, layer structural parameters, water content and viscoelastic properties to examine the properties of protein layers formed at the liquid/solid interface. Layer parameters were examined upon adsorption of proteins of varying size and structural properties, on surfaces with opposite polarity. We show that "soft" proteins such as unfolded α-synuclein and high molecular weight albumin are highly influenced by the surface polarity, as they form a highly diffuse and hydrated layer on the hydrophilic silica surface as opposed to the denser, less hydrated layer formed on a hydrophobic methylated surface. These layer properties are a result of different orientations and packing of the proteins. By contrast, lysozyme is barely influenced by the surface polarity due to its intrinsic structural stability. Interestingly, we show that for a similar molecular weight, the unfolded α-synuclein forms a layer with the highest percentage of solvation not related to surface coverage but resulting from the highest water content trapped within the protein. Together, these data reveal a trend in layer properties highlighting the importance of the interplay between protein and surface for the design of biomaterials.


Subject(s)
Muramidase/chemistry , Serum Albumin, Bovine/chemistry , Adsorption , Animals , Buffers , Cattle , Humans , Interferometry , Quartz Crystal Microbalance Techniques , Shear Strength , Surface Properties
11.
J Biol Chem ; 288(29): 20883-20895, 2013 Jul 19.
Article in English | MEDLINE | ID: mdl-23740253

ABSTRACT

There is increasing evidence for the involvement of lipid membranes in both the functional and pathological properties of α-synuclein (α-Syn). Despite many investigations to characterize the binding of α-Syn to membranes, there is still a lack of understanding of the binding mode linking the properties of lipid membranes to α-Syn insertion into these dynamic structures. Using a combination of an optical biosensing technique and in situ atomic force microscopy, we show that the binding strength of α-Syn is related to the specificity of the lipid environment (the lipid chemistry and steric properties within a bilayer structure) and to the ability of the membranes to accommodate and remodel upon the interaction of α-Syn with lipid membranes. We show that this interaction results in the insertion of α-Syn into the region of the headgroups, inducing a lateral expansion of lipid molecules that can progress to further bilayer remodeling, such as membrane thinning and expansion of lipids out of the membrane plane. We provide new insights into the affinity of α-Syn for lipid packing defects found in vesicles of high curvature and in planar membranes with cone-shaped lipids and suggest a comprehensive model of the interaction between α-Syn and lipid bilayers. The ability of α-Syn to sense lipid packing defects and to remodel membrane structure supports its proposed role in vesicle trafficking.


Subject(s)
Lipid Bilayers/metabolism , Membrane Lipids/chemistry , alpha-Synuclein/metabolism , Interferometry , Lipid Bilayers/chemistry , Melitten/metabolism , Membrane Proteins/metabolism , Models, Molecular , Permeability , Phospholipids/chemistry , Protein Binding , Protein Structure, Secondary , Tissue Extracts , Unilamellar Liposomes/chemistry , Unilamellar Liposomes/metabolism , alpha-Synuclein/chemistry
12.
Biomaterials ; 34(5): 1461-70, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23195491

ABSTRACT

Protein adsorption plays a crucial role in biomaterial surface science as it is directly linked to the biocompatibility of artificial biomaterial devices. Here, elucidation of protein adsorption mechanism is effected using dual polarization interferometry and a quartz crystal microbalance to characterize lysozyme layer properties on a silica surface at different coverage values. Lysozyme is observed to adsorb from sparse monolayer to multilayer coverage. At low coverage an irreversibly adsorbed layer is formed with slight deformation consistent with side-on orientation. At higher coverage values dynamic re-orientation effects are observed which lead to monolayer surface coverages of 2-3 ng/mm² corresponding to edge-on or/and end-on orientations. These monolayer thickness values ranged between 3 and 4.5 nm with a protein density value of 0.60 g/mL and with 50 wt% solvent mass. Further increase of coverage results formation of a multilayer structure. Using the hydration content and other physical layer properties a tentative model lysozyme adsorption is proposed.


Subject(s)
Enzymes, Immobilized/chemistry , Interferometry/instrumentation , Materials Testing/instrumentation , Micro-Electrical-Mechanical Systems/instrumentation , Muramidase/chemistry , Refractometry/instrumentation , Adsorption , Enzymes, Immobilized/analysis , Equipment Design , Equipment Failure Analysis , Humans , Muramidase/analysis , Protein Binding
SELECTION OF CITATIONS
SEARCH DETAIL
...